179 related articles for article (PubMed ID: 3899404)
1. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial.
Mok CK; Boey J; Wang R; Chan TK; Cheung KL; Lee PK; Chow J; Ng RP; Tse TF
Circulation; 1985 Nov; 72(5):1059-63. PubMed ID: 3899404
[TBL] [Abstract][Full Text] [Related]
2. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole.
Chesebro JH; Fuster V; Elveback LR; McGoon DC; Pluth JR; Puga FJ; Wallace RB; Danielson GK; Orszulak TA; Piehler JM; Schaff HV
Am J Cardiol; 1983 May; 51(9):1537-41. PubMed ID: 6342354
[TBL] [Abstract][Full Text] [Related]
3. Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
Brott WH; Zajtchuk R; Bowen TE; Davia J; Green DC
J Thorac Cardiovasc Surg; 1981 Apr; 81(4):632-5. PubMed ID: 7206773
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation therapy in children with mechanical prosthetic cardiac valves.
Bradley LM; Midgley FM; Watson DC; Getson PR; Scott LP
Am J Cardiol; 1985 Sep; 56(8):533-5. PubMed ID: 4036839
[TBL] [Abstract][Full Text] [Related]
5. High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Heras M; Chesebro JH; Fuster V; Penny WJ; Grill DE; Bailey KR; Danielson GK; Orszulak TA; Pluth JR; Puga FJ
J Am Coll Cardiol; 1995 Apr; 25(5):1111-9. PubMed ID: 7897124
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet therapy in children with left-sided mechanical prostheses.
LeBlanc JG; Sett SS; Vince DJ
Eur J Cardiothorac Surg; 1993; 7(4):211-5. PubMed ID: 8481259
[TBL] [Abstract][Full Text] [Related]
8. Preliminary experience with aspirin for anticoagulation in children with prosthetic cardiac valves.
Weinstein GS; Mavroudis C; Ebert PA
Ann Thorac Surg; 1982 Jun; 33(6):549-53. PubMed ID: 6178379
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial.
Rafiq S; Steinbrüchel DA; Lilleør NB; Møller CH; Lund JT; Thiis JJ; Køber L; Olsen PS
Thromb Res; 2017 Feb; 150():104-110. PubMed ID: 27914653
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet and anticoagulation for patients with prosthetic heart valves.
Little SH; Massel DR
Cochrane Database Syst Rev; 2003; (4):CD003464. PubMed ID: 14583979
[TBL] [Abstract][Full Text] [Related]
11. Dipyridamole combined with anticoagulant in prevention of early postoperative thromboembolism after cardiac valve replacement.
Kawazoe K; Fujita T; Manabe H
Thromb Res Suppl; 1990; 12():27-33. PubMed ID: 2082485
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation in children with mechanical valve prostheses.
Bradley SM; Sade RM; Crawford FA; Stroud MR
Ann Thorac Surg; 1997 Jul; 64(1):30-4; discussion 35-6. PubMed ID: 9236331
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulants and the Björk-Shiley prosthesis. Experience of 390 patients.
Sutton MG; Miller GA; Oldershaw PJ; Paneth M
Br Heart J; 1978 May; 40(5):558-62. PubMed ID: 656224
[TBL] [Abstract][Full Text] [Related]
14. Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis.
Massel D; Little SH
J Am Coll Cardiol; 2001 Feb; 37(2):569-78. PubMed ID: 11216981
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement.
Puskas JD; Gerdisch M; Nichols D; Fermin L; Rhenman B; Kapoor D; Copeland J; Quinn R; Hughes GC; Azar H; McGrath M; Wait M; Kong B; Martin T; Douville EC; Meyer S; Ye J; Jamieson WRE; Landvater L; Hagberg R; Trotter T; Armitage J; Askew J; Accola K; Levy P; Duncan D; Yanagawa B; Ely J; Graeve A;
J Am Coll Cardiol; 2018 Jun; 71(24):2717-2726. PubMed ID: 29903344
[TBL] [Abstract][Full Text] [Related]
16. Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study.
Gherli T; Colli A; Fragnito C; Nicolini F; Borrello B; Saccani S; D'Amico R; Beghi C
Circulation; 2004 Aug; 110(5):496-500. PubMed ID: 15289387
[TBL] [Abstract][Full Text] [Related]
17. Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
Nuñez L; Pinto AG; Larrea JL; Gil Aguado M; Connor FO
Z Kardiol; 1986; 75 Suppl 2():321-5. PubMed ID: 3727711
[No Abstract] [Full Text] [Related]
18. Pharmacologic control of thromboembolic complications of cardiac-valve replacement.
Sullivan JM; Harken DE; Gorlin R
N Engl J Med; 1971 Jun; 284(25):1391-4. PubMed ID: 4931099
[No Abstract] [Full Text] [Related]
19. Preventive treatment of cerebral transient ischemia: comparative randomized trial of pentoxifylline versus conventional antiaggregants.
Herskovits E; Famulari A; Tamaroff L; Gonzalez AM; Vázquez A; Dominguez R; Fraiman H; Vila J
Eur Neurol; 1985; 24(1):73-81. PubMed ID: 3881263
[TBL] [Abstract][Full Text] [Related]
20. Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents.
Apollonio A; Castignani P; Magrini L; Angeletti R
J Int Med Res; 1989; 17(1):28-35. PubMed ID: 2651175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
